Contribution Agreements in the Biotechnology Industry

85 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Strategic Innovation Fund Contribution Agreement among His Majesty the King in Right of Canada, Variation Biotechnologies Inc., and VBI Vaccines Inc.
Contribution Agreements
VBI Vaccines Inc
Biotechnology
2024
Asset Contribution Agreement between AgeX Therapeutics, Inc. and UniverXome Bioengineering, Inc. dated March 26, 2024
Contribution Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Sale, Contribution and Servicing Agreement between XOMA (US) LLC, XOMA Corporation, and XRL 1 LLC dated December 15, 2023
Contribution Agreements
XOMA Corp
Biotechnology
DE
2024
Asset Contribution Agreement between Pfizer Inc. and Allogene Therapeutics, Inc. (April 2, 2018)
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2023
Contribution and Assignment Agreement between Cibus Global, LLC and Cibus Charitable Foundation, Inc. dated May 3, 2022
Contribution Agreements
Calyxt, Inc.
Biotechnology
DE
2023
Contribution and Satisfaction of Indebtedness Agreement among Sorrento Therapeutics, Scilex Holding Company, and Scilex Pharmaceuticals (September 12, 2022)
Contribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2022
Contribution and Servicing Agreement between Trevena, Inc. and Trevena SPV2 LLC dated March 30, 2022
Contribution Agreements
TREVENA INC
Biotechnology
DE
2022
Amendment No. 1 to Strategic Innovation Fund Contribution Agreement among Her Majesty the Queen in Right of Canada, Variation Biotechnologies Inc., and VBI Vaccines Inc.
Contribution Agreements
VBI Vaccines Inc
Biotechnology
2022
Contribution Agreement between Homology Medicines, Inc. and Roadrunner Solutions LLC dated March 10, 2022
Contribution Agreements
Homology Medicines, Inc.
Biotechnology
DE
2022
Contribution, Assignment and Assumption Agreement among Lian Oncology, Lian Oncology HK, and LianBio
Contribution Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement among LianBio Licensing, Lian Oncology, and LianBio dated September 28, 2021
Contribution Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement among Lian Oncology, Lian Oncology HK, and LianBio
Contribution Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement among LianBio Licensing, Lian Oncology, and LianBio
Contribution Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement among Lian Cardiovascular, Lian Cardiovascular HK, and LianBio
Contribution Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement among LianBio Licensing, Lian Cardiovascular, and LianBio
Contribution Agreements
LianBio
Biotechnology
NY
2021
Rallybio Holdings, LLC Contribution and Restricted Share Agreement with Recipient
Contribution Agreements
Rallybio Corp
Biotechnology
DE
2021
Asset Contribution Agreement between Carnot, LLC and Eliem Therapeutics, Inc. (February 4, 2019)
Contribution Agreements
Eliem Therapeutics, Inc.
Biotechnology
2021
Contribution and Exchange Agreement between Monte Rosa Therapeutics AG Shareholders and Monte Rosa Therapeutics, Inc.
Contribution Agreements
Monte Rosa Therapeutics, Inc.
Biotechnology
DE
2021
Contribution and Exchange Agreement between Monte Rosa Therapeutics AG Shareholders and Monte Rosa Therapeutics, Inc.
Contribution Agreements
Monte Rosa Therapeutics, Inc.
Biotechnology
DE
2021
Contribution Agreement among PearlRiver Bio GmbH, United Medicines Biopharma Limited, and Sellers (December 31, 2020)
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Sellers, United Medicines Biopharma Limited, and Pega-One S.A.S. (January 23, 2021)
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Z Factor Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Orexia Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Morphogen-IX Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among LockBody Therapeutics Ltd, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Janpix Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Inexia Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among Capella Bioscience Ltd, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement among APCINTEX Limited, the Sellers, and United Medicines Biopharma Limited dated January 23, 2021
Contribution Agreements
Centessa Pharmaceuticals Ltd
Biotechnology
2021
Contribution Agreement between Medovex Corp. and Medovex, LLC for DenerveX Device Assets
Contribution Agreements
Medovex Corp.
Biotechnology
DE
2021
Cullinan Management, Inc. and Cullinan Oncology, LLC Contribution Agreement
Contribution Agreements
Cullinan Oncology, LLC
Biotechnology
DE
2021
Strategic Innovation Fund Contribution Agreement for VBI COVID-19 Project between Her Majesty the Queen in Right of Canada, Variation Biotechnologies Inc., and VBI Vaccines Inc.
Contribution Agreements
VBI Vaccines Inc
Biotechnology
2020
Contribution and Exchange Agreement among 89bio, Inc., 89bio Ltd., and Equityholders
Contribution Agreements
89bio, Inc.
Biotechnology
DE
2019
Contribution Agreement among TacticGem LLC, Monopar Therapeutics Inc., Gem Pharmaceuticals, LLC, and Tactic Pharma, LLC (August 25, 2017)
Contribution Agreements
Monopar Therapeutics
Biotechnology
DE
2019
Contribution Agreement among TacticGem LLC, Monopar Therapeutics Inc., Gem Pharmaceuticals, LLC, and Tactic Pharma, LLC (August 25, 2017)
Contribution Agreements
Monopar Therapeutics
Biotechnology
DE
2019
Contribution Agreement among TacticGem LLC, Monopar Therapeutics Inc., Gem Pharmaceuticals, LLC, and Tactic Pharma, LLC (August 25, 2017)
Contribution Agreements
Monopar Therapeutics
Biotechnology
DE
2019
Contribution Agreement among TacticGem LLC, Monopar Therapeutics Inc., Gem Pharmaceuticals, LLC, and Tactic Pharma, LLC dated August 25, 2017
Contribution Agreements
Monopar Therapeutics
Biotechnology
DE
2019
Asset Contribution and Separation Agreement between Alliqua BioMedical, Inc. and AquaMed Technologies, Inc. dated May 3, 2019
Contribution Agreements
Alliqua BioMedical, Inc.
Biotechnology
DE
2019
Contribution Agreement to the Property of Trust F/2868 between Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie, and Oncbiomune Pharmaceuticals, Inc.
Contribution Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Asset Contribution Agreement between Transposagen Biopharmaceuticals, Inc. and Poseida Therapeutics, Inc.
Contribution Agreements
Poseida Therapeutics, Inc.
Biotechnology
DE
2019